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Inoculation of C. difficile cultures and production of toxin
The bacterial toxin was recovered from the NAP-1/027 strain of C. difficile (positive for both TcdA and TcdB) provided by Dr. Tom Louie (Calgary, AB, Canada). The toxin production and extraction was completed as previously described [27] . The protein concentration of the final TcdA/B mixture was determined by Bradford assay, and this mixture was used as the toxin source for all experiments.
Intestinal epithelial cell culture Caco-2 colorectal adenocarcinoma cell line (ATCC, USA -cell #: HTB-37, designation: Caco-2) were cultured in Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, USA) with 20% fetal bovine serum (FBS; Invitrogen, USA), 1% penicillin-streptomycin solution (PenStrep; Invitrogen, USA), 1% non-essential amino acid solution (NEAA; Invitrogen, USA) and 1% sodium pyruvate solution (Invitrogen, USA). In some experiments, Caco-2 cells with stable expression of siRNA targeting HIF-1α (HIF-1α-KD) or the corresponding scrambled control (HIF-1α-SCR) were used for some experiments. The chosen siRNAs with the sequence 5'-ACC TCG CTG ACC AGT TAT GAT TGT GAT CAA GAG TCA CAA TCA TAA CTG GTC AGC TT-3' and 5'-CAA AAA GCT GAC CAG TTA TGA TTG TGA CTC TTG ATC ACA ATC ATA ACT GGT CAG CG-3' corresponding to position 2666-2685 of the HIF-1α gene were used as previously described [18] . HIF-1 α-KD and HIF-1 α -SCR cells were cultured in DMEM (Cellgro -Mediatech, USA), with 10% FBS, 1% PenStrep, 1% L-glutamine (Invitrogen, USA) and 3 µg/mL of puromycin (Invitrogen, USA). Maintenance of the HIF-1α-KD and HIF-1α-SCR Caco-2 cells followed the same protocol as described for the wild-type Caco-2 cells. Cell cultures were incubated at 37 °C under 5% CO 2 in 100 cm 2 Petri dishes and used for experiments at 90% confluence.
Caco-2 cell treatment and extraction of cellular proteins
Monolayers were treated with: C. difficile TcdA/B toxin mixture, the selective iNOS inhibitor 1400W dihydrochloride (1400W, dissolved in PBS; SIGMA-Aldrich, USA), or the ROS scavenger, N-acetyl L-cysteine (NAC, dissolved in PBS; SIGMA-Aldrich, USA). For the majority of the experiments, TcdA/B toxin was added at a concentration of 70 µg/mL. Treatments (i.e., 1400W [28] , 100 µM and NAC, 25 mM) were added 1 hour prior to the addition of TcdA/B. Cells were lysed with HEN/2 buffer (125 mM HEPES, pH 7.7, 0.5 mM EDTA, and 50 mM neocuproine with 0.2% (v/v) NP-40 and Complete Protease Inhibitor). Supernatants, collected via centrifugation at 17,500g (i.e., cytosolic fraction), were collected. Pellets were reconstituted in 150 µL nuclear extract buffer (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 10% (v/v) glycerol, and 0.1 mM neocuproine). The reconstituted pellets were then incubated for 2 hours at 4 °C, followed by highspeed centrifugation at 17,500g for 5 minutes at 4 °C. The resulting supernatant represented the nuclear fraction of the cell. Due to the light-sensitive nature of NO and its associated modifications, all samples were prepared in opaque Eppendorf tubes. Lee 
Immunoprecipitation of HIF-1α
Protein G agarose bead slurry (25 µL; diluted 1:2 with HEN/2 buffer) was combined with nuclear extract sample or colonic tissue homogenate, pre-cleared at 4 °C for 15 min and then centrifuged at 17,500g. The protein concentration of the resulting supernatant was determined by Bradford assay, and samples were normalized based on protein concentration. Each sample was incubated with HIF-1α antibody (1 µg; ab1/H1α67, Abcam, USA) at 4 °C for 12 hours with gentle rocking. Protein G agarose (25 µL) was added, and the beads were collected by centrifugation. The supernatant was carefully extracted and discarded, and the beads were washed 4 times with ice-cold PBS. The HIF-1 α-immunoprecipitates were used immediately for immunoblotting or the biotin-switch assay.
Immunoblotting
Western blotting was performed on cell extracts or mouse tissue homogenates. Membranes were incubated with a specific primary antibody diluted 1:1000 in TBST containing 5% milk overnight at 4 °C. The following primary antibodies were used: HIF-1α (ab1/h1α67 -Abcam, USA), iNOS (ab3523 -Abcam, USA), FIH-1 (ab63163/HIF1AN -Abcam, USA), and β-actin (A5316/AC-74 -SIGMA Aldrich, USA). The following secondary antibodies were used: HRP conjugated goat anti-mouse IgG (Bio-Rad, USA) and HRPconjugated donkey anti-rabbit IgG (GE Healthcare, USA).
Biotin Switch Assay
The biotin switch assay was conducted using the S-nitrosylated protein detection kit (Cayman Chemical, USA). The protocol was performed in very low-light conditions to protect the labile, nitrosylated residues. The manufacturer's suggested protocol was modified slightly to incorporate HIF-1α immunoprecipitation samples instead of whole cell extracts. In brief, the PBS-suspended HIF-1α immunoprecipitates were centrifuged (200g, 4 °C) to pellet the G protein agarose beads. The PBS was slowly decanted off the beads, and the samples were placed on ice. Blocking Buffer was added to each sample (250 µL of Blocking Buffer for 25 µL of beads) prior to incubation at 4 °C for 30 minutes. The beads were then washed extensively with ice-cold PBS before incubation with Reducing and Labeling Buffer for 1 hour at room temperature. After extensive washing with PBS, the supernatant was decanted from the beads and discarded. An equal volume of 2X Non-reducing Buffer was added to the samples and then heated to boiling for 5 minutes, placed on ice for 5 minutes, and then centrifuged at 17,500g. The supernatant was carefully decanted from the beads and then loaded onto a 10% SDS-PAGE gel. The gel was then subjected to standard immunoblotting protocol. Membranes were blocked overnight in 5% (w/v) bovine serum albumin (BSA) in TBST. This was followed by incubation with Streptavidin-HRP (Millipore, USA) at 1:1000 dilution in 5% (w/v) BSA in TBST.
Nitric oxide detection assay
For the detection of NO in cytosolic cell extracts, the Bioxytech Nitric Oxide Assay kit (OXIS Health Products Inc., USA) was used. The concentration of nitrite in each sample of cell extract was determined from the standard curve and then related to the protein content of each sample as determined previously by the Bradford assay.
In vivo model of C. difficile toxin exposure C57/Bl6 mice (male; 10-12 weeks; Charles River, Sherbrooke, QC, Canada) were used. C. difficile toxins were provided by intrarectal instillation as previously described [29] . TcdA/B (50 mg; 100 μL in PBS) or control saline (PBS alone) was slowly administered over 30 seconds while pressure was applied to the anal area to prevent leakage. All animal experiments were approved by the Animal Care Committee of the University of Calgary and conform to the guidelines set forth by the Canadian Council for Animal Care. The health and welfare of each mouse was assessed in 30 min intervals until the animals were euthanized.
Statistics
All numerical data are reported as the mean ± standard error of the mean (SEM). For some immunoblotting experiments, representative duplicate samples are shown in figures; however, these were combined and considered to be n = 1 experimental value. All graphical data and associated statistical analyses were generated with GraphPad PRISM 4 (GraphPad, USA). Statistics for experiments comparing 2 sets of parametric data were calculated using the Student's t-test. Experiments comparing more than 2
Results
In a previous study, intestinal HIF-1α expression and signaling was linked to NO generated by iNOS [27] . We further assessed the association among C. difficile toxin exposure, iNOS expression and HIF-1α stabilization in Caco-2 IECs. A 2.4-fold increase in iNOS expression relative to control was observed at 4 hours exposure of Caco-2 IECs with C. difficile toxins (Fig. 1A) . Elevated levels of NO were also detected in these cells suggesting that the increase in iNOS expression was linked to a direct increase in NO production. With respect to HIF-1α, an increase in the expression relative to control (no toxin exposure) was also observed at 4 hours (Fig. 1B) , indicating a possible correlation with changes in iNOS expression and cellular NO concentrations. As previously identified, nitrosylation of HIF-1α on specific cysteine residues can effectively stabilize the cellular protein levels [22] . Furthermore, nitrosylation of other modulators of HIF-1 signaling have also been suggested, including von-Hippel Lindau protein (pVHL; [23, 30] ), factor inhibiting HIF-1 (FIH-1; [23] Fig. 1. Exposure of Caco-2 epithelial cell monolayers to C. difficile toxins elicits alterations in iNOS, FIH-1 and HIF-1α expression as well as HIF-1α nitrosylation. Caco-2 monolayers were exposed to C. difficile toxins (TcdA/B, 70 µg/mL) for 2 -12 h with control (vehicle) cells harvested at 12 h. Cell extracts were examined for iNOS (A), HIF-1α protein (B) and nitrosylation (C), and FIH-1 (D). Expression levels of iNOS and FIH-1 were normalized against β-actin as a loading control. HIF-1α nitrosylation was measured by the biotin switch assay on immunoprecipitates with the data presented as biotin switch signal relative to HIF-1α protein levels. Values are reported as mean ± S.E.M., n=3. * -significantly different from control (one-way ANOVA with Neuman-Keuls post hoc test, p < 0.01). and thioredoxin [31] . So we also examined if C. difficile toxin exposure influenced HIF-1α nitrosylation levels with a Biotin Switch Assay (Fig. 1C) . Levels of nitrosylated HIF-1α reached a peak at 4 hours suggesting that its accumulation occurred coincident with C. difficile toxindependent increases in iNOS expression and NO production. FIH-1, a known inhibitor of HIF-1 signaling, was also analyzed following exposure of cells to C. difficile toxins. Over the course of a 12 hour exposure, Caco-2 IEC monolayers experienced a significant decrease in FIH-1 protein levels when compared to control beginning at the 4 hour mark and continuing through to 12 hours (Fig. 1D) .
The results of experiments presented in Figure 1 suggested that the TcdA/B effects on iNOS expression could influence HIF-1α stabilization via a feed-forward mechanism. The highly selective iNOS inhibitor, 1400W, was applied in order to verify that HIF-1α nitrosylation, and therefore HIF-1α protein stabilization, was directly linked to NO derived from iNOS. Similar to previous experiments, we observed significant stabilization of HIF-1α protein levels following exposure of Caco-2 IEC monolayers to TcdA/B for 4 hours (Fig.  2A) . In addition, FIH-1 expression was reduced with TcdA/B exposure (Fig. 2B) . However, when cells were pre-incubated with 1400W and then exposed to TcdA/B, HIF-1α expression (A), NO production was quantified as the concentration of nitrite in cell extracts using a modified Griess assay. Cell extracts were immunoblotted for HIF-1α (A) and FIH-1 (B), and expression levels were normalized to β-actin as a loading control. Nitric oxide was quantified as the concentration of nitrite in cell extracts using a modified Griess assay (C), and iNOS protein levels (D) were examined by immunoblotting. In (E), HIF-1α was immunoprecipitated from nuclear extracts and then subjected to the biotin switch assay for measurement of protein nitrosylation. The data are presented as biotin switch signal relative to HIF-1α protein levels. Values are reported as mean ± S.E.M., n=4. * -significantly different from control; # -significantly different from TcdA/B exposure (one-way ANOVA with Neuman-Keuls post hoc test, p < 0.01). In (F), Caco-2 cell monolayers were examined by immunocytochemistry of ZO-1 staining for epithelial tight junction integrity. ZO-1 immunostaining was visualized with fluorescence microscopy of Cy3-conjugated secondary antibody. The images are representative of n=3 independent treatments of different Caco-2 monolayers. Scale bar = 100 µm. Lee 
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was suppressed (to control levels; Fig. 2A ) and FIH-1 expression was elevated (returned to control levels; Fig. 2B ). Coincident with these responses, NO and iNOS expression levels ( Fig. 2C and 2D , respectively) returned to basal levels in the presence of 1400W. Finally, the nitrosylation of HIF-1α, which was elevated 2.5-fold above control with TcdA/B exposure, was also attenuated with iNOS inhibition (Fig. 2E) . These results suggest that NO generated by iNOS in response to C. difficile toxin exposure plays a key role in modulating the levels of both HIF-1α and FIH-1 proteins. C. difficile toxins influence the stability of the cytoskeleton (via glycosylation of the Rho family of small G-proteins [32] ) and cause disruption of tight junctions between adjacent intestinal epithelial cells [7] . A key tight junctional protein found along the periphery of IECs is zonula occludens (ZO)-1 [33] , and we assessed the integrity of epithelial tight junctional complexes upon exposure to C. difficile toxins with immunocytochemistry of ZO-1 (Fig. 2F) . Control monolayers displayed the characteristic membrane-distributed staining of ZO-1. Exposure to C. difficile toxins resulted in noticeable changes to the continuity of the monolayer, cellular morphology (e.g., the cells were reduced in size with some rounding occurring at the edges) and dramatic reorganization of ZO-1 staining. Application of 1400W had no effect on cellular structure or tight junctional integrity as neither ZO-1 staining nor appearance of the monolayer was altered. However, administration of 1400W in concert with C. difficile toxins appeared to exacerbate disruptions in monolayer morphology and tight junctional integrity. ZO-1 staining became increasingly diffuse and cytosolic in nature, and cells were greatly reduced in size with significant rounding with almost complete disruption of the monolayer.
From the data presented, NO produced by iNOS appears to be important for the modulation of HIF-1α stabilization and signaling during exposure of Caco-2 IECs to C. difficile toxin. The regulation of iNOS expression by HIF-1 has been previously reported [16, 34] , so we employed Caco-2 IECs with constitutive siRNA-mediated knockdown of HIF-1α (HIF-KD) [35] to determine whether TcdA/B effects on iNOS were HIF-1α-dependent. Prior to performing any experiments, we confirmed that the HIF-KD cells, along with scrambled siRNA (HIF-SCR) control cells, demonstrated the appropriate HIF-1α response. Only the HIF-SCR Caco-2 cells showed the expected increase in HIF-1α (Fig. 3) when a HIF-1α stabilizing compound (i.e., CoCl 2 ) was applied. It should be noted that these cells do not represent a genetic deletion of HIF-1α; therefore it is not surprising that some basal level of HIF-1α protein expression was present in the HIF-KD cells. Upon administration of TcdA/B, HIF-1α protein levels were increased in the HIF-SCR cells (Fig. 4A, panel iii) but not in the HIF-KD cells (Fig. 4B, panel  iii) . Exposure to C. difficile toxins caused a significant increase in both iNOS expression and NO availability in the HIF-SCR cells (Fig. 4A, panels i and ii respectively) , but the increases in NO and iNOS expression were not observed in HIF-KD cells (Fig. 4B, panels i and ii) . A lack of measurable increase in HIF-1α nitrosylation coincided with the absence of changes in NO in the HIF-KD cells (Fig. 4B, panel iv) . On the surface, these findings suggest a possible 
When cells were pre-treated with the selective iNOS inhibitor, 1400W, the increases observed for both iNOS and HIF-1α were effectively abolished along with the increase in NO itself.
Further examination of the HIF-1α subunit demonstrated that the protein was subjected to nitrosylation when Caco-2 IEC monolayers were exposed to TcdA/B. Moreover, isolation of HIF-1α from an in vivo model of C. difficile intoxication also revealed nitrosylation events that correlated with increases in HIF-1α stabilization. These findings suggest that NO generated via iNOS is necessary for the nitrosylation and stabilization of HIF-1α and are particularly important as they represent the mechanism whereby HIF-1α protein levels are elevated to offer innate protection in the presence of C. difficile toxins.
Other studies have identified that C. difficile toxins and other actin cytoskeletondisrupting agents are capable of inducing iNOS expression [38] [39] [40] . It was demonstrated that iNOS expression was induced in the presence of cytokines during TcdB exposure [39] . TcdA is also capable of rapidly inducing cytokine and chemokine production, the increases seen as early as 10 minutes with a peak response occurring after 2 hours of toxin exposure [41] . These data correspond with our observed increases in iNOS induction that occur after 4 hours of toxin exposure. A number of studies have identified NF-κB as being a major inducer of cytokine-mediated iNOS expression [41, 42] . However, iNOS can also be induced by disruption of the actin cytoskeleton in an NF-κB-independent fashion [40] . Since the major action of the Clostridial toxins is to facilitate the disruption of the cytoskeleton, it is possible that C. difficile toxins induce iNOS expression independent of NF-κB signaling.
In addition to these mechanisms, the data gathered herein from Caco-2 HIF-KD cells reveal a positive feedback nature of the iNOS/HIF-1 regulation in the context of C. difficile toxin exposure. When treated with Clostridial toxins, WT Caco-2 and HIF-SCR cells respond with increased HIF-1α stabilization and iNOS induction. In contrast, HIF-KD cells that displayed deficiencies in HIF-1α induction, toxin exposure was accompanied by suppressed HIF-1α responses and iNOS induction. With HIF-1α implicated in a number of cellular processes, it comes as no surprise that the iNOS gene also contains a hypoxia response element for HIF-1 transcriptional regulation within its promoter region [16] . Additional studies investigating the HIF-1α-mediated induction of bactericidal factors (which include NO) identified mice with macrophages deficient in HIF-1α to harbor greater amounts of colonized bacteria compared to WT, suggesting NO production and bactericidal responses to be suppressed by the lack of HIF-1α [14] . Taken together, these findings support a requirement for HIF-1α C. difficile toxin (TcdA & TcdB; 100 µg in 100 µL) was administered per rectum to C57Bl/6 mice. Control mice were provided 100 µL of PBS as a vehicle control. Colonic tissue homogenates were immunoblotted for HIF-1α (A); expression levels were normalized to β-actin as a loading control. In (B), HIF-1α was immunoprecipitated from tissue homogenates (200 µg total protein) and subjected to the biotin switch assay. The data are presented as biotin switch signal relative to HIF-1α protein levels. Values are reported as mean ± S.E.M., n=3. * -significantly different from vehicle control (Student's t-test, p < 0.05).
signaling in the induction of iNOS expression as an innate protective response to C. difficile toxin exposure. Moreover, our data suggests that a positive feedback loop exists in this signaling pathway, with NO derived from the increased iNOS expression providing additional HIF-1 signaling capacity via nitrosylation and stabilization of HIF-1α protein levels.
It is important to note that elevations in NO are frequently associated with concurrent increases in ROS production. In the context of C. difficile intoxication, both TcdA and TcdB are capable of causing significant increases in ROS levels [36, 43] . As a therapeutic, NAC has been shown to possess cytoprotective properties by acting as a potent ROS scavenger in a variety of experimental models [44] . NAC has been demonstrated to impair cellular intoxication during TcdB exposure with the protective effect of NAC hypothesized to result from its ability to alter the redox environment and provide stabilization of cytoskeletal integrity [45] . TcdB exposure of human epithelial cells created an oxidizing cellular environment (represented by an increase in oxidized glutathione), and this oxidative imbalance as well as cytoskeleton-dependent cell retraction and rounding was rectified with NAC treatment. Based on our results, it appears that ROS also interacts with the NO/iNOS system to promote the nitrosylation and stabilization of protective HIF-1α signaling. Assuming that NAC acts as a ROS scavenger in our system, the findings suggest that ROS may be an essential factor in the stabilization of HIF-1α in the context of C. difficile toxin exposure.
FIH-1, as mentioned previously, is asparagine hydroxylase enzyme that is involved in the suppression of HIF-1 downstream transcriptional activity. Our experiments demonstrate a possible novel connection between NO and FIH-1. Namely, NO may be involved in destabilizing FIH-1 expression to hinder its hydroxylation of HIF-1α. Studies previously demonstrated that NO donors could inhibit FIH-1 activity, which subsequently promoted interactions of HIF-1α with its transcriptional co-activators [23] . It was initially suspected that nitrosylation of the Cys-800 site on HIF-1α protected against the asparagine hydroxylation by FIH-1; however, the data of Park et al. [23] suggest NO could directly inhibit the hydroxylase activity of FIH-1 itself. These data support our findings concerning FIH-1 regulation in the presence of TcdA/B and 1400W. However, in the HIF-KD cells, NO levels were not altered, yet FIH-1 expression was still suppressed in both TcdA/B and NAC + TcdA/B treatments. Since NAC alone does not affect FIH-1 expression, it is also possible that FIH-1 expression was suppressed by TcdA/B in an NO-independent manner.
In another model of intestinal injury, the integrated actions of NO and HIF-1 were investigated in rats that were subjected to intestinal damage with indomethacin [46] . iNOS, HIF-1 and intestinal trefoil factor (ITF; a downstream gene target of HIF) were found to be elevated, and HIF-1α was also shown to be nitrosylated in the animals that were provided the indomethacin treatment. Moreover, when rats were given 1400W in conjunction with indomethacin, a reduction in the amount of HIF-1α detected was observed. This attenuation did not significantly modify the damage induced by indomethacin; however, it did serve to impede ITF function with respect to epithelial barrier restitution. This resulted in a delayed healing response in mice treated with both 1400W and IM, compared to those treated with just indomethacin. Taken together the findings of this study suggest that the decrease in HIF-1α nitrosylation (and subsequent stabilization) was connected to a decrease in barrier restitution via HIF-1-mediated transcriptional activation of ITF. These findings agree with our study in that iNOS is necessary for the induction of HIF-1α stabilization via nitrosylation. Therefore it is possible that the decrease in stabilized HIF-1α has a greater consequence with respect to downstream signaling and wound healing following C. difficile toxin exposure rather than the immediate damage response. Finally, a recent study demonstrated that NO produced in response to C. difficile elicited nitrosylation of C. difficile toxins themselves [30] . The trans-nitrosylation of different cysteine residues, including ones located in the catalytic cysteine protease region, were shown to inhibit both autocatalysis and cell entry of the toxin [30] . These studies, along with our current study, demonstrate the increasing importance of NO in mounting a crucial cellular defense response to C. difficile toxins.
